Skip to main content

Table 4 Mean difference in laboratory test results at the end of the maintenance period

From: Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China

Change from Day 56 to baseline

Lanthanum carbonate

Placebo

P value

Mean(95% CI)(Lanthanum carbonate -Placebo)

Calcium (mmol/L)

    

No. of patients (Missing)

108(7)

110(5)

  

Mean(SD)

0.02(0.32)

−0.02(0.19)

0.035

0.04(−0.03, 0.11)

Variation of Ca × P (mg2/dl2)

    

No. of patients (Missing)

108(6)

109(4)

  

Mean(SD)

4.02(15.02)

17.46(17.97)

< 0.001

−13.44(−17.87,-9.00)

iPTH (pg/ml)

    

No. of patients (Missing)

109(5)

110(3)

  

Mean(SD)

19.60(182.81)

53.63(136.88)

0.017

−34.03(−77.02,8.96)

  1. iPTH, intact parathyroid hormone.